SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about voting results of EGM

10 Jul 2015 Evaluate

Aurobindo Pharma has informed regarding the details of voting results at the Extra Ordinary General Meeting (EGM) of the Company held on July 09, 2015, under Clause 35A.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1370.50 -15.15 (-1.09%)
20-Apr-2026 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.20
Dr. Reddys Lab 1235.00
Cipla 1232.20
Zydus Lifesciences 936.50
Lupin 2331.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×